Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of Bezafibrate in Mitochondrial Myopathy
2015-000508-24Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bezafibrate in Mitochondrial myopathies (MM), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Change in respiratory chain enzyme activity. Started May 2015; status: completed.
02
Drugs
bezafibrate
03
Conditions
Mitochondrial myopathies (MM)
Beyond the preview
Go deeper on 2015-000508-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000508-24.